Generic drugmaker Mylan goes hostile in bid for Perrigo

(Reuters) - Generic drugmaker Mylan NV said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is set to be one of the most high-profile hostile...